Log in to search using one of your social media accounts:

This page shows you the latest news items in this category. This is page number 8.

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include seat belts and motor vehicle fatalities, lupus in pregnancy (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - June 21, 2015 Category: OBGYN Source Type: news

Allegheny Health Network's Susan Manzi, MD, Receives National...
Susan Manzi, MD, MPH, Chair of the Department of Medicine at Allegheny Health Network, was presented with the Lupus Foundation of America’s National Advocacy Leadership Award this week in Washington,...(PRWeb June 18, 2015)Read the full story at http://www.prweb.com/releases/2015/06/prweb12796448.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 19, 2015 Category: Pharmaceuticals Source Type: news

Depression as a common complication of systemic lupus erythematosus - Lemaire B, Geron D, Malaise O, Krzesinski JM, Ansseau M, Scantamburlo G.
Systemic lupus erythematosus (SLE) is an inflammatory disease with multiple and disabling consequences, including the psychological status. The prevalence of major depressive episodes among patients suffering from SLE is significantly higher than in health... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - June 12, 2015 Category: Global & Universal Tags: Suicide and Self-Harm Source Type: news

Autoimmunity: New immunoregulation and biomarker
Clinicians have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases like multiple sclerosis and lupus erythematosus. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 12, 2015 Category: Science Source Type: news

Lupus Nephritis Therapeutic Development Pipeline Review H1 2015 Market...
RnRMarketResearch.com adds “Lupus Nephritis – Pipeline Review, H1 2015” to its store. The report provides an overview of the Lupus Nephritis’s therapeutic pipeline.(PRWeb June 10, 2015)Read the full story at http://www.prweb.com/releases/lupus-nephritis-pipeline/review-h1-2015-market/prweb12779381.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 12, 2015 Category: Pharmaceuticals Source Type: news

Autoimmunity: New immunoregulation and biomarker
(Ludwig-Maximilians-Universität München) Clinicians at Ludwig-Maximilians-Universitaet in Munich have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases like multiple sclerosis and lupus erythematosus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 12, 2015 Category: Global & Universal Source Type: news

UCLA researchers discover molecular rules that govern autoimmune disorders
UCLA Engineering Bundles with the right DNA spacing can amplify immune response. An international team led by researchers at UCLA’s Henry Samueli School of Engineering and Applied Science and California NanoSystems Institute has identified an unexpectedly general set of rules that determine which molecules can cause the immune system to become vulnerable to the autoimmune disorders lupus and psoriasis. The breakthrough, described in an article published today in the journal Nature Materials, could lead to new ways of treating the disorders. Led by Gerard C. L. Wong, a UCLA professor of bioengineering and chemistry who i...
Source: UCLA Newsroom: Health Sciences - June 8, 2015 Category: Universities & Medical Training Source Type: news

Researchers expose how 'James Bond' cells are made
New research has revealed how immune cell 'spies' are created, providing clues on how the immune system could be manipulated to better fight disease. Dendritic cells are intelligence-gathering immune cells, gathering information on viruses, bacteria, cancer and fungi to aid the immune system in fighting disease. Understanding how dendritic cells are created will aid scientists in finding ways to boost the immune response to infections or dampen it in autoimmune diseases such as lupus and rheumatoid arthritis, experts say. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 8, 2015 Category: Science Source Type: news

Researchers expose how 'James Bond' cells are made
(Walter and Eliza Hall Institute) New research from Australian and Singaporean scientists has revealed how immune cell 'spies' are created, providing clues on how the immune system could be manipulated to better fight disease.Dendritic cells are intelligence-gathering immune cells, gathering information on viruses, bacteria, cancer and fungi to aid the immune system in fighting disease. Understanding how dendritic cells are created will aid scientists in finding ways to boost the immune response to infections or dampen it in autoimmune diseases such as lupus and rheumatoid arthritis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 8, 2015 Category: Infectious Diseases Source Type: news

Subgroup Responds to Rontalizumab in Lupus (CME/CE)
(MedPage Today) -- Some benefits seen for those with low interferon gene expression (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 4, 2015 Category: Primary Care Source Type: news

Nonprofits launch web campaign to raise awareness about scleroderma
Three North American nonprofit organizations that invest in scleroderma research are jointly trying to raise awareness about the autoimmune disorder. Their efforts include posting information and urging people to pledge to raise awareness about the disease on Facebook and Twitter channels... (Source: Skin and Allergy News)
Source: Skin and Allergy News - June 2, 2015 Category: Dermatology Tags: FPN News FPN Dermatology FPN Rare Diseases FPN Rheumatology IMN News RHEUM News RHEUM Lupus/Connective Tissue Diseases Source Type: news

My Daughter's Mysterious Illness -- And My Own
For TueNight.com by Allison Czarnecki (Photos: Courtesy Allison Czarnecki. Photos from left to right: Allison and her daughter as a baby, Allison's daughter in the hospital getting tests, Allison's daughter now; Photo collage: Helen Jane Hearn/TueNight.com) Exactly one year ago, my teenage daughter got sick. Really sick. One day, out of the blue, she woke up and couldn't get out of bed. Up to this point, my then 14-year-old daughter had been a wildly healthy, state-championship swimmer who played the cello in an honors orchestra, earned straight As in all her classes. She was heavily involved in leadership positions in...
Source: Healthy Living - The Huffington Post - June 1, 2015 Category: Consumer Health News Source Type: news

Lupus Nephritis: Multiple Factors for Tx Success (CME/CE)
(MedPage Today) -- Absence of anti-dsDNA antibodies, cyclophosphamide induction linked to better outcomes. (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - May 29, 2015 Category: Urology & Nephrology Source Type: news

Inflammatory Claims About Inflammation
We all appreciate the elegance of simple solutions to complex problems. But we know too that simplicity can often masquerade as truth, hiding a more nuanced reality. Such is the case with inflammation, where pseudoscience, exaggerated claims, false promises, and dangerous oversimplification have dominated for too long. Here is a typical missive: "Inflammation controls our lives. Have you or a loved one dealt with pain, obesity, ADD/ADHD, peripheral neuropathy, diabetes, heart disease, stroke, migraines, thyroid issues, dental issues, or cancer? If you answered yes to any of these disorders you are dealing with inflammatio...
Source: Science - The Huffington Post - May 29, 2015 Category: Science Source Type: news

Suicide in systemic lupus erythematosus - Matsukawa Y.
[Abstract unavailable] Language: en... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - May 27, 2015 Category: Global & Universal Tags: Suicide and Self-Harm Source Type: news

Bob Saget Shines a Light on Scleroderma With Cool Comedy -- Hot Cuisine
In 1982, management consultant and former competitive figure skater, Sharon Monsky was diagnosed with scleroderma (in Latin "hard skin") a rare, potentially fatal disease that hardens the skin and internal organs and often strikes women of child-bearing age. Given two years to live, Sharon was shocked at how few, even in the medical community, were aware of the disease. Her response was to make possible what seemed impossible. She applied her business expertise to found the Scleroderma Research Foundation (S.R.F.), which, to date, has raised over 35 million dollars and provided medical breakthroughs through tireless resear...
Source: Healthy Living - The Huffington Post - May 27, 2015 Category: Consumer Health News Source Type: news

Rate ratio of comorbidity high in SLE patients under 40
MANCHESTER, U.K. – When systemic lupus erythematosus (SLE) occurs before age 40, patients run a high relative risk of end-stage renal disease, data from a retrospective U.K.-based cohort study have shown. While the risk for cardiovascular disease and stroke has been reported previously,... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 20, 2015 Category: Dermatology Tags: CME-candidate FPN Conferences IMN Conferences RHEUM Conference News SAN Conference News FPN News FPN Nephrology FPN Rheumatology HOSP News Source Type: news

BSR: Patient selection key to using rituximab in lupus
MANCHESTER, U.K. – Although around half of patients with refractory systemic lupus erythematous (SLE) benefit from rituximab treatment at 6 months, there is a subgroup of patients that appears to do worse, according to research presented at the British Society for Rheumatology annual... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 12, 2015 Category: Dermatology Tags: CME-candidate RHEUM Conference News FPN Conferences IMN Conferences SAN Conference News FPN News FPN Rheumatology RHEUM News Source Type: news

9 Common Symptoms Of Fibromyalgia And What To Do If You're Diagnosed
Today is National Fibromyalgia Awareness Day, which raises awareness for a chronic disorder that impacts an estimated five million adults in the United States, and is characterized by widespread pain and tenderness, often accompanied by fatigue, impaired memory and other physical issues. The condition may occur with other chronic pain conditions, such as osteoarthritis, rheumatoid arthritis and lupus. The exact cause of fibromyalgia is unknown, but researchers believe it could be the result of several factors, including genetics, illness and physical or emotional trauma, which lead to an abnormal processing of pain. In t...
Source: Science - The Huffington Post - May 12, 2015 Category: Science Source Type: news

BSR: Lengthy SLE remission is possible, late relapses occur
MANCHESTER – Complete remissions of at least 3 years were achieved by nearly 15% of patients with systemic lupus erythematous, based on a retrospective analysis of an observational, single-center cohort of 624 patients treated over a 32-year span. Nearly 5% of the patients achieved complete... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 11, 2015 Category: Dermatology Tags: CME-candidate RHEUM Conference News SAN Conference News RHEUM News RHEUM Lupus/Connective Tissue Diseases SAN Clinical News SAN News Source Type: news

IMB, 23andMe Launch Personalized Medicine Initiatives To Tackle Cancer, Lupus
A targeted cancer treatment project involving IBM’s Watson and a lupus research study led by personal genomics company 23andMe and drug maker Pfizer are two of the latest initiatives seeking to advance the growing field of personalized medicine. Both programs will study people's unique genetic profiles to guide decisions on preventing, diagnosing, and treating gene-linked conditions. (Source: Medical Design Online News)
Source: Medical Design Online News - May 8, 2015 Category: Medical Equipment Source Type: news

IBM, 23andMe Launch Personalized Medicine Initiatives To Tackle Cancer, Lupus
A targeted cancer treatment project involving IBM’s Watson and a lupus research study led by personal genomics company 23andMe and drug maker Pfizer are two of the latest initiatives seeking to advance the growing field of personalized medicine. Both programs will study people's unique genetic profiles to guide decisions on preventing, diagnosing, and treating gene-linked conditions. (Source: Medical Design Online News)
Source: Medical Design Online News - May 8, 2015 Category: Medical Equipment Source Type: news

Statin Myth A New Factor In Diabetes
Over the past two decades, I have watched with increasing alarm the skyrocketing numbers of patients with type 2 diabetes who come to my wellness clinic. Often, they come to see me about other medical issues, but their diabetes adds a new level of complications to their treatment. Type 2 diabetes occurs when the body’s response to insulin – the hormone critical for the maintenance of healthy blood sugar levels – becomes either ineffective or the insulin itself is produced in insufficient amounts. The horrific trend I’m seeing at my wellness clinic mirrors almost exactly what’s happening in the rest of...
Source: Al Sears, MD Natural Remedies - May 6, 2015 Category: Complementary Medicine Authors: Dr. Al Sears Tags: Nutrition diabetes insulin statins type 2 diabetes Source Type: news

Post-Transplant LN Patients Can Have Viable Pregnancies
(MedPage Today) -- Outcomes better in women with inactive systemic lupus erythematosus. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 6, 2015 Category: Primary Care Source Type: news

23andMe launches the lupus research study in collaboration with Pfizer Inc.
(Edelman) 23andMe, Inc., the leading personal genetics company, today announced the launch of the Lupus Research Study in collaboration with Pfizer Inc. The companies aim to enroll 5,000 individuals with systemic lupus erythematosus, more commonly known as lupus, into the study to help better understand the genetics of lupus. The effort is also in collaboration with the Lupus Research Institute, and in concert with Lupus Awareness Month in May. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 5, 2015 Category: Global & Universal Source Type: news

Drug-Induced Lupus Rate Low With Anti-TNF (CME/CE)
(MedPage Today) -- Most cases consisted solely of skin involvement. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 5, 2015 Category: Dermatology Source Type: news

Baseline CT scans predict lung fibrosis in SSc
Patients with newly diagnosed systemic sclerosis should have a high-resolution lung CT and pulmonary function tests, because when assessed together, their findings identify patients at high risk of interstitial lung disease, researchers say. In a study of 305 patients with systemic sclerosis... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 2, 2015 Category: Dermatology Tags: CME-candidate IMN News RHEUM News RHEUM Lupus/Connective Tissue Diseases CHEST Pulmonary Medicine CHEST Clinical News CHEST News FPN News Source Type: news

Domestic dogs (Canis lupus familiaris) and forensic practice - Byard RW.
In this editorial the specific contribution of domestic dogs (Canis lupus familiaris) to forensic issues is focused on. Dogs have long been associated with human activities and may be involved with the forensic evaluation of cases at a number of levels ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - May 2, 2015 Category: Global & Universal Tags: Home and Consumer Product Safety Source Type: news

Leukocytoclastic vasculitis incidence underestimated
ASHEVILLE, N.C. – The incidence of leukocytoclastic vasculitis in the general population is 1.5 to 3 times higher than previously reported, based on data from a large, population-based study. Based on these findings, leukocytoclastic vasculitis (LCV) is “more common than cutaneous lupus,” said Dr.... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 1, 2015 Category: Dermatology Tags: SAN Conference News FPN Conferences IMN Conferences RHEUM Conference News SAN Clinical News SAN News FPN News IMN News Source Type: news

Rituxan in Lupus: Responses Vary
(MedPage Today) -- Almost 60% improved at 3 months, yet 20% worsened at 6 months. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 30, 2015 Category: Primary Care Source Type: news

Being a victim or an aggressor: Different functions of triadic post-conflict interactions in wolves (Canis lupus lupus) - Cordoni G, Palagi E.
Animals adopt different behavioral strategies to cope with the conflict of interests coming from the competition over limited resources. Starting from the study on chimpanzees, post-conflict third-party affiliation (the affiliative contact provided by a th... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - April 28, 2015 Category: Global & Universal Tags: Research Methods, Surveillance and Codes, Models Source Type: news

Male Fetal Cells May Protect Women With Lupus Nephritis (CME/CE)
(MedPage Today) -- SLE female patients previously pregnant with male fetuses had better renal function. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - April 24, 2015 Category: Rheumatology Source Type: news

Researchers will evaluate ustekinumab’s ability to treat lupus
The effectiveness of treating lupus with a drug approved for treating plaque psoriasis and active psoriatic arthritis will be tested in a clinical study. The study, which will be conducted by the Alliance for Lupus Research and Janssen Research & Development, LLC, will evaluate the drug,... (Source: Skin and Allergy News)
Source: Skin and Allergy News - April 23, 2015 Category: Dermatology Tags: RHEUM Lupus/Connective Tissue Diseases RHEUM News SAN Clinical News SAN News SAN Psoriasis Source Type: news

Re-engineering lupus into a cancer killer
Researchers have devised a way to re-engineer lupus antibodies to turn them into potential cancer killers. Lupus is a chronic inflammatory disease that occurs when the immune system attacks its own organs, tissues, or joints. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 21, 2015 Category: Science Source Type: news

Haematological Manifestations of LupusHaematological Manifestations of Lupus
Which hematological abnormalities are common findings in patients with SLE? Lupus Science & Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 20, 2015 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

What Causes Bullae?
Discussion Bullae are fluid-filled epidermal lesions that are filled with serous or seropurulent fluid. They are > 1 cm in diameter and often easily rupture due to their thin walls. The differential diagnosis is different for bullae than for vesicular lesions with bullae being often more worrisome. However there is overlap and vesicular diseases can become large enough to be bullae. Drug toxicity and genetic problems are also more common in bullae whereas vesicles are more often caused by infectious diseases. Potentially life threatening conditions such as toxic epidermal necrolysis syndrome, Stevens Johnson syndrome o...
Source: PediatricEducation.org - April 20, 2015 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Vitamin D Tracks Systemic Lupus Erythematosus Activity (CME/CE)
(MedPage Today) -- Study first in Southern Hemisphere to examine role of vitamin D in SLE disease activity (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 16, 2015 Category: Primary Care Source Type: news

Azathioprine and Mycophenolate Mofetil Comparable in Lupus NephritisAzathioprine and Mycophenolate Mofetil Comparable in Lupus Nephritis
In a 10-year follow-up study, European investigators found no difference in long-term outcomes between patients given mycophenolate mofetil (MMF) or azathioprine as maintenance therapy for proliferative lupus nephritis. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 14, 2015 Category: Consumer Health News Tags: Rheumatology News Source Type: news

TWEAK/Fn14 interactions associated with cutaneous lupus pathogenesis
Interactions between TNF-like weak inducer of apoptosis and its receptor Fn14 are significantly associated with the pathogenesis of cutaneous lupus, according to Dr. Jessica Doerner and her associates. Treating murine keratinocytes with TWEAK stimulated both RANTES, a T cell important in the... (Source: Skin and Allergy News)
Source: Skin and Allergy News - April 7, 2015 Category: Dermatology Tags: SAN Journals SAN Clinical News SAN News SAN Atopic Dermatitis RHEUM Journal RHEUM News RHEUM Lupus/Connective Tissue Diseases Source Type: news

Study identifies protein that triggers lupus-associated immune system activation
(Massachusetts General Hospital) Massachusetts General Hospital investigators have found that a protein that regulates certain cells in the innate immune system -- the body's first line of defense against infection -- activates a molecular pathway known to be associated with the autoimmune disorder systemic lupus erythematosus and that the protein's activity is required for the development of lupus symptoms in a mouse model of the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2015 Category: Global & Universal Source Type: news

Mood Disorders Hamper Quality of Life in SLE (CME/CE)
(MedPage Today) -- Some mood disorders may respond to systemic lupus erythematosus therapies over time. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 28, 2015 Category: Primary Care Source Type: news

Vitamin D Won't Diminish Interferon-Inducible Gene Expression in SLE (CME/CE)
(MedPage Today) -- Supplements don't affect gene expression in lupus patients. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 27, 2015 Category: Primary Care Source Type: news

NYU Leads the Way in Lupus Pregnancy (CME/CE)
(MedPage Today) -- Focus on risk factors for adverse outcomes and preventing congenital heart block. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 26, 2015 Category: Cardiology Source Type: news

Lupus: How does it affect the kidneys?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - March 26, 2015 Category: Consumer Health News Source Type: news

Disease Damage Rises Steadily in Lupus (CME/CE)
(MedPage Today) -- Contributing factors included steroid use, disease activity, and hypertension. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 24, 2015 Category: Rheumatology Source Type: news

The Untold Story Of How Dogs Became Our Best Friends
Dogs and humans have been BFFs for a very long time -- at least 10,000 years. No surprise there. But have you ever wondered just how dogs and other animals got domesticated, and why? And how today's domesticated animals differ from their wild predecessors? The story is even more complicated than you might imagine. To learn more about how man's best friend came to be -- and how dogs changed the course of human history -- check out the video above, and/or read the transcript below. Don't forget to leave your thoughts in the comments. Talk nerdy to me! CLICK HERE FOR FULL TRANSCRIPT They’re our best friends! Around ...
Source: Science - The Huffington Post - March 23, 2015 Category: Science Source Type: news

'Ground Zero' Workers At Risk of Autoimmune Diseases
Prolonged exposure linked to rheumatoid arthritis, lupus Source: HealthDay Related MedlinePlus Pages: Autoimmune Diseases, Occupational Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 19, 2015 Category: Consumer Health News Source Type: news

Lupus Nephritis Histology Predicts Long-Term Outcomes (CME/CE)
(MedPage Today) -- Class IV disease associated with poorer 5-year remission rates. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 13, 2015 Category: Primary Care Source Type: news

High-Dose Steroids May Trigger Organ Damage in Lupus (CME/CE)
(MedPage Today) -- Organ damage risk doubled with daily doses of 20 mg prednisone. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 12, 2015 Category: Primary Care Source Type: news

Two Regimens Equivalent in Lupus Nephritis (CME/CE)
(MedPage Today) -- 10-year study confirms: it's a toss-up between mycophenolate mofetil and azathioprine. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 11, 2015 Category: Primary Care Source Type: news